DE69824234D1 - Menschliche-"CDR-grafted"-Antikörper gegen Gangliosid gm2 - Google Patents
Menschliche-"CDR-grafted"-Antikörper gegen Gangliosid gm2Info
- Publication number
- DE69824234D1 DE69824234D1 DE69824234T DE69824234T DE69824234D1 DE 69824234 D1 DE69824234 D1 DE 69824234D1 DE 69824234 T DE69824234 T DE 69824234T DE 69824234 T DE69824234 T DE 69824234T DE 69824234 D1 DE69824234 D1 DE 69824234D1
- Authority
- DE
- Germany
- Prior art keywords
- cdr
- seq
- chain
- human
- ganglioside
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
- C07K2317/732—Antibody-dependent cellular cytotoxicity [ADCC]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
- C07K2317/734—Complement-dependent cytotoxicity [CDC]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Analytical Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Endocrinology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP06698197A JP4550947B2 (ja) | 1997-03-19 | 1997-03-19 | ガングリオシドgm2に対するヒト型相補性決定領域(cdr)移植抗体 |
| JP6698197 | 1997-03-19 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69824234D1 true DE69824234D1 (de) | 2004-07-08 |
| DE69824234T2 DE69824234T2 (de) | 2005-06-23 |
Family
ID=13331716
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69824234T Expired - Lifetime DE69824234T2 (de) | 1997-03-19 | 1998-03-19 | Menschliche"CDR-grafted"-Antikörper gegen Gangliosid GM2 |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0882794B1 (de) |
| JP (1) | JP4550947B2 (de) |
| AT (1) | ATE268382T1 (de) |
| AU (1) | AU751948B2 (de) |
| CA (1) | CA2226400C (de) |
| DE (1) | DE69824234T2 (de) |
| ES (1) | ES2219802T3 (de) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6407734B1 (en) | 1994-10-31 | 2002-06-18 | Nec-Mitsubishi Electric Visual Systems Corporation | Power supply system capable of reducing power consumption during interruption of an external input signal given to an operating circuit |
| US7241568B2 (en) | 1996-04-03 | 2007-07-10 | Kyowa Hakko Kogyo Co., Ltd. | Anti-fibroblast growth factor-8 monoclonal antibody |
| DK1176195T3 (da) | 1999-04-09 | 2013-06-24 | Kyowa Hakko Kirin Co Ltd | Fremgangsmåde til at kontrollere aktiviteten af immunologisk funktionelt molekyle |
| US6693176B1 (en) | 1999-07-23 | 2004-02-17 | University Of Massachusetts | Antitumor antibodies, proteins, and uses thereof |
| AU7449200A (en) * | 1999-09-30 | 2001-04-30 | Kyowa Hakko Kogyo Co. Ltd. | Derivatives of antibody against ganglioside gm2 |
| AU2016204535C1 (en) * | 2000-04-12 | 2017-02-23 | Laboratoire Français Du Fractionnement Et Des Biotechnologies | Anti-D monoclonal antibodies |
| FR2807767B1 (fr) * | 2000-04-12 | 2005-01-14 | Lab Francais Du Fractionnement | Anticorps monoclonaux anti-d |
| JP2001299349A (ja) * | 2000-04-19 | 2001-10-30 | Suntory Ltd | 新規組換え型抗体とそのcdrのアミノ酸配列およびそれをコードする遺伝子 |
| US6946292B2 (en) | 2000-10-06 | 2005-09-20 | Kyowa Hakko Kogyo Co., Ltd. | Cells producing antibody compositions with increased antibody dependent cytotoxic activity |
| EA013224B1 (ru) * | 2000-10-06 | 2010-04-30 | Киова Хакко Кирин Ко., Лтд. | Клетки, продуцирующие композиции антител |
| AU2002346127B2 (en) * | 2001-06-28 | 2008-05-29 | Kyowa Hakko Kirin Co., Ltd. | Humanized antibody against fibroblast growth factor-8 and fragment of the antibody |
| WO2003049704A2 (en) | 2001-12-11 | 2003-06-19 | University Of Massachusetts | Antibodies to treat cancer |
| ATE429249T1 (de) * | 2001-12-28 | 2009-05-15 | Kyowa Hakko Kogyo Kk | Anti-fgf-8 antikörper gegen arthritis |
| AU2003236017B2 (en) | 2002-04-09 | 2009-03-26 | Kyowa Kirin Co., Ltd. | Drug containing antibody composition |
| US20040115204A1 (en) | 2002-12-11 | 2004-06-17 | Fanger Gary R. | Antibodies to treat cancer |
| AU2004279736A1 (en) * | 2003-10-09 | 2005-04-21 | Kyowa Hakko Kirin Co., Ltd. | Antibody composition specifically binding to ganglioside GM2 |
| US7691810B2 (en) | 2003-10-09 | 2010-04-06 | Kyowa Hakko Kirin Co., Ltd | Method of producing recombinant antithrombin III composition |
| EP2107115A1 (de) | 2007-01-24 | 2009-10-07 | Kyowa Hakko Kirin Co., Ltd. | Genetisch rekombinante antikörperzusammensetzung zur anbindung insbesondere an gangliosid gm2 |
| FR2953841B1 (fr) * | 2009-12-16 | 2011-12-30 | Centre Nat Rech Scient | Anticorps diriges contre le recepteur de la transferrine et leurs utilisations pour l'immunotherapie des tumeurs qui dependent du fer |
| EP2543727B1 (de) | 2010-03-02 | 2016-08-31 | Kyowa Hakko Kirin Co., Ltd. | Modifizierte antikörperzusammensetzung |
| JP6310397B2 (ja) * | 2012-12-06 | 2018-04-11 | 国立大学法人金沢大学 | 中皮腫の治療方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU669379B2 (en) * | 1992-09-07 | 1996-06-06 | Kyowa Hakko Kirin Co., Ltd. | Humanized antibodies |
-
1997
- 1997-03-19 JP JP06698197A patent/JP4550947B2/ja not_active Expired - Lifetime
-
1998
- 1998-03-19 EP EP98105047A patent/EP0882794B1/de not_active Expired - Lifetime
- 1998-03-19 AT AT98105047T patent/ATE268382T1/de not_active IP Right Cessation
- 1998-03-19 CA CA002226400A patent/CA2226400C/en not_active Expired - Lifetime
- 1998-03-19 DE DE69824234T patent/DE69824234T2/de not_active Expired - Lifetime
- 1998-03-19 ES ES98105047T patent/ES2219802T3/es not_active Expired - Lifetime
- 1998-03-19 AU AU59420/98A patent/AU751948B2/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| EP0882794B1 (de) | 2004-06-02 |
| JPH10257893A (ja) | 1998-09-29 |
| ATE268382T1 (de) | 2004-06-15 |
| AU5942098A (en) | 1998-10-01 |
| EP0882794A3 (de) | 1999-06-16 |
| JP4550947B2 (ja) | 2010-09-22 |
| CA2226400C (en) | 2008-12-02 |
| CA2226400A1 (en) | 1998-09-19 |
| AU751948B2 (en) | 2002-09-05 |
| EP0882794A2 (de) | 1998-12-09 |
| ES2219802T3 (es) | 2004-12-01 |
| DE69824234T2 (de) | 2005-06-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69824234D1 (de) | Menschliche-"CDR-grafted"-Antikörper gegen Gangliosid gm2 | |
| FR12C0004I2 (fr) | Anticorps contre l'antigene ctla-4 humain et utilisation | |
| WO1998050433A3 (en) | Human monoclonal antibodies to epidermal growth factor receptor | |
| TR200101831T2 (tr) | CTLA-4 için insan monoklonal antikorları. | |
| CA2290485A1 (en) | Method for the production of non-immunogenic proteins | |
| ATE373712T1 (de) | Natürlicher menschlicher antikörper | |
| WO1998018826A3 (en) | Anti-CCR5 antibodies and methods of use therefor | |
| NZ503763A (en) | Antigenic compositions and vaccines comprising a high molecular weight (HMW) protein of Clamydia for therapeutic and prophylactic use | |
| CA2267072A1 (en) | Reconstituted human anti-hm1.24 antibody | |
| DK1157042T3 (da) | Fremstilling af tetravalente antistoffer | |
| FI973354A0 (fi) | MAG-geenejä | |
| EE05497B1 (et) | Polüpeptiid, lahustuv CRAM-1 polüpeptiid, polünukleotiid ja antikeha | |
| EP1530579A4 (de) | Rekombinante antikörper sowie zusammensetzungen und verfahren zu deren herstellung und verwendung | |
| NO943653L (no) | Rekombinante, humane HIV-nöytraliserende monoklonale antistoffer for forebyggelse og behandling av HIV-infeksjon | |
| DE69922834D1 (de) | Humanisierter antikörper spezifisch für das oberflächenantigen pre-s1 von hbv und dessen präparation | |
| GR3034035T3 (en) | A process for the preparation of factor ix from biological sources | |
| AU3582593A (en) | Antigen recognized by patients with antibody associated lambert-eaton myasthenic syndrome (LEMS), DNA encoding same and uses thereof | |
| EP1191096A4 (de) | Neues protein und dessen dns | |
| DE59207362D1 (de) | Monoklonale Antikörper gegen den Plasmin-Antiplasmin Komplex, Verfahren zu ihrer Herstellung sowie ihre Verwendung | |
| BR9911388A (pt) | Imunógeno de somatostatina sintético para promoção de crescimento em animais de fazenda | |
| SE9600436D0 (sv) | Vaccine against hantavirus | |
| WO2020232243A3 (en) | Antibodies to sudan and ebola virus | |
| IT1291419B1 (it) | Gruppo illuminante per l'illuminazione di acquari,terrari e simili. | |
| DE69128095D1 (de) | Azelluläre impfstoffe | |
| AU2293300A (en) | Ewing's tumour antigen, nucleic acid and antibodies |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8327 | Change in the person/name/address of the patent owner |
Owner name: KYOWA HAKKO KIRIN CO., LTD., TOKYO, JP |